SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 138 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $122,000 | -89.6% | 10,300 | -90.8% | 0.01% | -87.2% |
| Q2 2017 | $1,171,000 | +3.3% | 111,500 | +7.8% | 0.04% | +2.6% |
| Q2 2016 | $1,134,000 | -60.7% | 103,400 | -38.0% | 0.04% | -47.2% |
| Q4 2015 | $2,882,000 | -23.0% | 166,700 | -11.6% | 0.07% | -49.7% |
| Q3 2015 | $3,745,000 | +248.4% | 188,500 | +188.2% | 0.14% | +410.7% |
| Q2 2015 | $1,075,000 | +60.9% | 65,400 | +52.4% | 0.03% | +47.4% |
| Q1 2015 | $668,000 | – | 42,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,304,376 | $23,414,000 | 7.30% |
| Kassirer Asset Management Corp | 291,784 | $5,238,000 | 5.39% |
| First Trust Capital Management L.P. | 637,578 | $11,445,000 | 2.19% |
| NEXTHERA CAPITAL LP | 510,486 | $9,163,000 | 1.69% |
| HAVENS ADVISORS LLC | 100,000 | $1,795,000 | 1.35% |
| Piermont Capital Management Inc. | 172,980 | $3,105,000 | 1.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 674,446 | $12,106,000 | 0.97% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 1,495,600 | $26,845,000 | 0.96% |
| LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 200,000 | $3,590,000 | 0.87% |
| BOOTHBAY FUND MANAGEMENT, LLC | 332,075 | $5,961,000 | 0.87% |